VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
Xiujuan Li,Narendra Padhan,Elisabet O. Sjöström,Francis P. Roche,Chiara Testini,Naoki Honkura,Miguel Sáinz-Jaspeado,Emma Gordon,Katie Bentley,Andrew Philippides,Vladimir Tolmachev,Elisabetta Dejana,Radu V. Stan,Dietmar Vestweber,Kurt Ballmer-Hofer,Christer Betsholtz,Kristian Pietras,Leif Jansson,Lena Claesson-Welsh
DOI: https://doi.org/10.1038/ncomms11017
IF: 16.6
2016-03-23
Nature Communications
Abstract:The specific role of VEGFA-induced permeability and vascular leakage in physiology and pathology has remained unclear. Here we show that VEGFA-induced vascular leakage depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2Y949F/Y949F leads to VEGFA-resistant endothelial adherens junctions and a block in molecular extravasation. Vessels in Vegfr2Y949F/Y949F mice remain sensitive to inflammatory cytokines, and vascular morphology, blood pressure and flow parameters are normal. Tumour-bearing Vegfr2Y949F/Y949F mice display reduced vascular leakage and oedema, improved response to chemotherapy and, importantly, reduced metastatic spread. The inflammatory infiltration in the tumour micro-environment is unaffected. Blocking VEGFA-induced disassembly of endothelial junctions, thereby suppressing tumour oedema and metastatic spread, may be preferable to full vascular suppression in the treatment of certain cancer forms.
multidisciplinary sciences